Picard Medical is trading 10.72% up in pre-market today at $5.68 after reporting approximately $2.95 million in second-quarter revenue, nearly double the roughly $1.55 million consensus estimate. - Revenue increased 39%, driven by stronger U.S. sales. - Gross profit reached approximately $0.6 million. - The earnings-driven move follows a 59.81% gain to $5.13 on August 24, 2026, indicating continued heavy investor interest.